Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors

$296,752U54FY2001CANIH

University Of Texas Md Anderson Can Ctr, Houston TX

Investigators

Linked publications & trials

Paper 21041626 Paper 20945416 Paper 20008624 Paper 19671758 Paper 19478644 Paper 19424760 Paper 19383922 Paper 18815812 Paper 18583538 Paper 18344436 Paper 18316544 Paper 18094400 Paper 18072754 Paper 18047347 Paper 18045060 Paper 17909916 Paper 17724345 Paper 17656319 Paper 17548657 Paper 17379450 Paper 17351389 Paper 17150161 Paper 16951177 Paper 16871430 Paper 16787379 Paper 16685275 Paper 16631083 Paper 16585204 Paper 16581960 Paper 16510583 Paper 16507911 Paper 16373705 Paper 16357160 Paper 16183931 Paper 16183930 Paper 16163059 Paper 16103072 Paper 15898744 Paper 15867361 Paper 15827676 Paper 15802051 Paper 15735692 Paper 15735682 Paper 15701856 Paper 15681844 Paper 15671571 Paper 15585754 Paper 15546209 Paper 15488755 Paper 15479480 Paper 15380518 Paper 15324809 Paper 15292716 Paper 15231672 Paper 15214593 Paper 15206098 Paper 15197351 Paper 15133506 Paper 15126358 Paper 14998491 Paper 14749476 Paper 14744752 Paper 14734682 Paper 14734449 Paper 14688405 Paper 14630224 Paper 14613995 Paper 12932650 Paper 12884910 Paper 12858544 Paper 12810673 Paper 12782608 Paper 12751641 Paper 12631592 Paper 12611081 Paper 12538646 Paper 12496764 Paper 12470989 Paper 12402160 Paper 12242328 Paper 12228200 Paper 11821895 Paper 11689892 Paper 11571726

View original record on NIH RePORTER →